This webpage explains that persistent high-risk HPV—especially type 16—is a leading cause of oropharyngeal cancer, accounting for around 70% of U.S. throat cancers, and highlights prevention strategies like vaccination, sexual health practices, and regular screenings.
This fact sheet outlines that herpes simplex virus (HSV‑1 and HSV‑2) is a common, lifelong infection causing oral or genital blisters, transmitted via skin-to-skin or saliva contact—even when asymptomatic—and managed through antiviral treatment and preventive measures. It emphasizes that many individuals are unaware of their infection and underscores the role of condoms and suppressive therapy in reducing symptom recurrence and transmission.
This information sheet outlines how individuals can take a two‑pill (200 mg) dose of doxycycline within 24–72 hours after condomless oral, anal, or vaginal sex to significantly reduce the risk of syphilis, gonorrhea, and chlamydia. It provides clear dosing instructions, timing guidance, and encourages regular STI screening and care coordination.
This toolkit delivers updated data visualizations, infographics, and social media assets spotlighting the intersection of viral hepatitis and the opioid crisis—highlighting regional opioid prescribing rates alongside Hepatitis C mortality trends to support awareness campaigns during Hepatitis Awareness Month.
This guideline provides comprehensive, evidence-based recommendations on prophylaxis, treatment, immunization, and drug interactions for a wide range of pediatric OIs—including new additions for coccidioidomycosis, hepatitis B revaccination, and updated immunization schedules—to guide clinicians caring for HIV‑exposed and infected children.
This guideline offers updated, evidence-based recommendations—from preconception through postpartum—on universal prenatal HIV testing, preferred antiretroviral regimens (e.g., bictegravir/TAF/FTC), maternal viral monitoring, obstetric management, and neonatal prophylaxis to further reduce perinatal HIV transmission toward elimination goals (defined as <1% transmission rate and <1 infection per 100,000 live births).
This information sheet offers an in-depth analysis of current AFP models—including funding mechanisms, stakeholder roles, and implementation strategies—to support sustainability of HIV-related services beyond traditional grant funding. It outlines key considerations and best practices to help health departments and community partners explore and launch innovative financing options for long-term epidemic response planning.
This toolkit supports Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Programs (ADAPs)—which provide access to HIV-related medications for low-income individuals—in navigating the planning, selection, and implementation of benefits management contracts. It offers key definitions, planning tools, real-world examples, and checklists to help ADAP administrators—new or experienced—align contractor selection with their program’s unique infrastructure and needs.
